KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Gross Profit (2017 - 2025)

Historic Gross Profit for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $607.0 million.

  • Elanco Animal Health's Gross Profit rose 1282.53% to $607.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year increase of 357.14%. This contributed to the annual value of $2.4 billion for FY2024, which is 201.13% down from last year.
  • Per Elanco Animal Health's latest filing, its Gross Profit stood at $607.0 million for Q3 2025, which was up 1282.53% from $713.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Gross Profit ranged from a high of $763.0 million in Q1 2023 and a low of $519.0 million during Q4 2023
  • For the 5-year period, Elanco Animal Health's Gross Profit averaged around $634.7 million, with its median value being $629.0 million (2021).
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 15068.97% in 2021, then crashed by 1192.37% in 2022.
  • Quarter analysis of 5 years shows Elanco Animal Health's Gross Profit stood at $602.0 million in 2021, then decreased by 10.8% to $537.0 million in 2022, then fell by 3.35% to $519.0 million in 2023, then changed by 0.0% to $519.0 million in 2024, then grew by 16.96% to $607.0 million in 2025.
  • Its Gross Profit was $607.0 million in Q3 2025, compared to $713.0 million in Q2 2025 and $684.0 million in Q1 2025.